0000911916-15-000152.txt : 20150507
0000911916-15-000152.hdr.sgml : 20150507
20150507123313
ACCESSION NUMBER: 0000911916-15-000152
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150505
FILED AS OF DATE: 20150507
DATE AS OF CHANGE: 20150507
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CoLucid Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001348649
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 203419541
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 15 NEW ENGLAND EXECUTIVE PARK
CITY: BURLINGTON
STATE: MA
ZIP: 01803
BUSINESS PHONE: 781-365-2596
MAIL ADDRESS:
STREET 1: 15 NEW ENGLAND EXECUTIVE PARK
CITY: BURLINGTON
STATE: MA
ZIP: 01803
FORMER COMPANY:
FORMER CONFORMED NAME: Colucid Pharmaceuticals Inc
DATE OF NAME CHANGE: 20060104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dallas Matthew D
CENTRAL INDEX KEY: 0001612396
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37358
FILM NUMBER: 15840471
MAIL ADDRESS:
STREET 1: AVEO PHARMACEUTICALS, INC.
STREET 2: 650 EAST KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-05-05
0001348649
CoLucid Pharmaceuticals, Inc.
CLCD
0001612396
Dallas Matthew D
15 NEW ENGLAND EXECUTIVE PARK
BURLINGTON
MA
01803
0
1
0
0
Chief Financial Officer
Employee Stock Option (Right to Buy)
10.00
2015-05-05
4
A
0
180254
0
A
2025-05-05
Common Stock
180254
180254
D
Options vest as follows: 25% of the shares vest on May 5, 2016; and the remaining shares vest in a series of 36 successive equal monthly installments upon completion of each additional month of service.
/s/ Miranda S. Hirner, Attorney-in-Fact for Matthew D. Dallas (power of attorney previously filed)
2015-05-07